Exposure of DCs to cyclo-oxygenaase-2 overexpressing gliomas results in IL-10 production by DCs which also drives Tr1 response, which may be dependent on robust secretion of Prostaglandin E2 from the glioma[25]. This evidence concerns the gene TNFRSF11B and central nervous system cancer.